ACRV - Balance Sheet - Acrivon Therapeutics, Inc. Common Stock

Current Liabilities	17.2 M
Accounts Payable	758 K
Short-Term Debt	1.06 M
Other Current Liabilities	15.4 M
Non-Current Liabilities	2.59 M
Long-Term Debt	0
Other Non-Current Liabilities	2.59 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020
ASSETS
Cash & Cash Equivalents	39.8	36.0	29.5	99.6	1.6
Short Term Investments	139.7	91.4	98.2	0	0
Receivables	0	0	0	0	0
Inventory	0	0	0	0	0
Other Current Assets	2.1	2.2	4.3	0.8	0.1
Total Current Assets	181.6	129.7	127.8	100.4	1.7
PP&E	8.0	7.9	6.9	5.8	59 K
Intangible Assets	0	0	0	0	0
Goodwill	0	0	0	0	0
Long Term Investments	5.1	0.4	41.9	0.4	0.4
Other Long Term Assets	1.8	0.3	4.7	0	0
Other Assets	0	0	0	0	0
Total Assets	196.6	138.3	181.2	106.6	2.2
LIABILITIES
Accounts Payable	0.8	5.0	0.9	1.0	0.1
Short Term Debt	1.1	0.9	1.5	0.7	58 K
Other Current Liabilities	15.4	7.4	4.1	1.2	0.4
Total Current Liabilities	17.2	13.3	6.5	2.9	0.6
Long Term Debt	0	3.8	4.2	5.0	0
Deferred Tax Income	0	0	0	0	0
Other Liabilities	0	0	0	122.5	0
Total Liabilities	19.8	17.1	10.8	130.4	10.6
EQUITY
Common Stock	31 K	23 K	22 K	2 K	1 K
Retained Earnings	(197.0)	(116.4)	(56.0)	(24.9)	(8.6)
Other Accumulative Comprehensive Income/Loss	0.4	83 K	95 K	0	0
Total Equity	176.8	121.2	170.5	(23.8)	(8.4)
Total Liabilities and Equity	196.6	138.3	181.2	106.6	2.2
SHARES OUTSTANDING
Common Shares Outstanding	337.9	22.1	21.9	20.9	20.9

Free